Inocras to Present New Results from Agentic AI Framework for Scaling Cancer Whole-Genome Sequencing Interpretation at AMP 2026
SAN DIEGO--(BUSINESS WIRE)--Inocras Inc., a bioinformatics-led company harnessing the power of whole-genome data and proprietary analytics to deliver curated insights, today announced that it will present the first public results from its multimodal agentic AI framework for automating variant curation and clinical interpretation of cancer whole-genome sequencing (WGS) analysis at the Association for Molecular Pathology (AMP) 2026 Annual Meeting & Expo, taking place November 10–14 in Seattle
The post Inocras to Present New Results from Agentic AI Framework for Scaling Cancer Whole-Genome Sequencing Interpretation at AMP 2026 appeared first on BusinessWire.
For more information, please visit http://www.businesswire.com/news/home/20261109381648/en/Inocras-to-Pre…